EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Programmatic Effectiveness of a Pediatric Typhoid Conjugate Vaccine Campaign in Navi Mumbai, India

Seth A Hoffman iD, Christopher LeBoa, Kashmira Date, Pradeep Haldar, Pauline Harvey, Rahul Shimpi, Qian An, Chenhua Zhang, Niniya Jayaprasad, Lily Horng, Kirsten Fagerli, Priyanka Borhade und 18 weitere

Clinical Infectious Diseases · 05.07.2023 · 77 (1) · 138-144

DOI: 10.1093/cid/ciad132 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 22.03.2023. Verfasst von Seth A Hoffman und 29 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Typhoid Fever, Typhoid-Paratyphoid Vaccines. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: World Health Organization, FIC NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The World Health Organization recommends vaccines for prevention and control of typhoid fever, especially where antimicrobial-resistant typhoid circulates. In 2018, the Navi Mumbai Municipal Corporation (NMMC) implemented a typhoid conjugate vaccine (TCV) campaign. The campaign targeted all children aged 9 months through 14 years within NMMC boundaries (approximately 320 000 children) over 2 vaccination phases. The phase 1 campaign occurred from 14 July 2018 through 25 August 2018 (71% coverage, approximately 113 420 children). We evaluated the phase 1 campaign's programmatic effectiveness in reducing typhoid cases at the community level.

Methods

We established prospective, blood culture–based surveillance at 6 hospitals in Navi Mumbai and offered blood cultures to children who presented with fever ≥3 days. We used a cluster-randomized (by administrative boundary) test-negative design to estimate the effectiveness of the vaccination campaign on pediatric typhoid cases. We matched test-positive, culture-confirmed typhoid cases with up to 3 test-negative, culture-negative controls by age and date of blood culture and assessed community vaccine campaign phase as an exposure using conditional logistic regression.

Results

Between 1 September 2018 and 31 March 2021, we identified 81 typhoid cases and matched these with 238 controls. Cases were 0.44 times as likely to live in vaccine campaign communities (programmatic effectiveness, 56%; 95% confidence interval [CI], 25% to 74%; P = .002). Cases aged ≥5 years were 0.37 times as likely (95% CI, .19 to .70; P = .002) and cases during the first year of surveillance were 0.30 times as likely (95% CI, .14 to .64; P = .002) to live in vaccine campaign communities.

Conclusions

Our findings support the use of TCV mass vaccination campaigns as effective population-based tools to combat typhoid fever.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Typhoid FeverTyphoid-Paratyphoid VaccinesAdolescentChildChild, PreschoolHumansInfantIncidenceIndiaProspective StudiesVaccines, AttenuatedVaccines, Conjugate

Stichwörter der Autor:innen

Salmonella TyphiIndiaglobal healthtyphoid fevervaccines

Substanzen

Typhoid-Paratyphoid VaccinesVaccines, AttenuatedVaccines, Conjugate

Autor:innen und Institutionen

  • Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
  • Global Immunization Division, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Ministry of Health & Family Welfare, Government of India, New Delhi, India.
  • World Health Organization-Country Office for India, National Public Health Surveillance Project, New Delhi, India.
  • Department of Pediatrics, NMMC General Hospital, Navi Mumbai, India.
  • Dr. Yewale Multispecialty Hospital for Children, Navi Mumbai, India.

ORCID-Profile: Seth A Hoffman, Stephen P Luby

Förderung

  • World Health Organization
  • FIC NIH HHS
  • NIAID NIH HHS
  • Bill & Melinda Gates Foundation
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases
  • Stanford Maternal and Child Health Research Institute

Zitieren

APA

Hoffman, S. A., LeBoa, C., Date, K., Haldar, P., Harvey, P., Shimpi, R., An, Q., Zhang, C., Jayaprasad, N., Horng, L., Fagerli, K., Borhade, P., Daruwalla, S., Dharmapalan, D., Gavhane, J., Joshi, S., Rai, R., Rathod, V., Shetty, K., …, & Luby, S. P. (2023). Programmatic Effectiveness of a Pediatric Typhoid Conjugate Vaccine Campaign in Navi Mumbai, India. Clinical Infectious Diseases, 77(1), 138-144. https://doi.org/10.1093/cid/ciad132

Vancouver

Hoffman SA, LeBoa C, Date K, Haldar P, Harvey P, Shimpi R, et al. Programmatic Effectiveness of a Pediatric Typhoid Conjugate Vaccine Campaign in Navi Mumbai, India. Clinical Infectious Diseases. 2023;77(1):138-144. doi:10.1093/cid/ciad132

BibTeX
@article{Hoffman2023,
  author = {Hoffman, Seth A and LeBoa, Christopher and Date, Kashmira and Haldar, Pradeep and Harvey, Pauline and Shimpi, Rahul and An, Qian and Zhang, Chenhua and Jayaprasad, Niniya and Horng, Lily and Fagerli, Kirsten and Borhade, Priyanka and Daruwalla, Savita and Dharmapalan, Dhanya and Gavhane, Jeetendra and Joshi, Shrikrishna and Rai, Rajesh and Rathod, Varsha and Shetty, Keertana and Warrier, Divyalatha S and Yadav, Shalini and Chakraborty, Debjit and Bahl, Sunil and Katkar, Arun and Kunwar, Abhishek and Yewale, Vijay and Andrews, Jason R and Bhatnagar, Pankaj and Dutta, Shanta and Luby, Stephen P},
  title = {Programmatic Effectiveness of a Pediatric Typhoid Conjugate Vaccine Campaign in Navi Mumbai, India},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  volume = {77},
  number = {1},
  pages = {138--144},
  doi = {10.1093/cid/ciad132}
}
Kostenlos starten →